News
OPRX
12.15
0.00%
0.00
Earnings Scheduled For March 28, 2024
Universal Stainless is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Walgreens Boots Alliance is likely to report earnings for its fourth quarter. Companies Reporting Before The Bell include Shimmick and Universal Stainless. Companies reporting after the bell include INmune Bio and Oxford Industries.
Benzinga · 1d ago
OptimizeRx Q4 2023 Earnings Preview
OptimizeRx (OPRX) is scheduled to announce Q4 earnings results on Thursday, March 28th. The consensus EPS Estimate is $0.26 and the consensus revenue estimate is $26.47M. OPRX has beaten EPS estimates 75% of the time in the last 2 years.
Seeking Alpha · 1d ago
Notable earnings before Thursday's open
Seeking Alpha · 1d ago
Weekly Report: what happened at OPRX last week (0318-0322)?
Weekly Report · 3d ago
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
OptimizeRx Corp. Will hold a conference call on March 28, 2024, to discuss the preliminary, unaudited results for the fourth quarter. The company is the leading provider of healthcare technology solutions to life sciences companies. The conference call will be held at 8:30 a.m. Eastern Time.
Barchart · 4d ago
OptimizeRx: Exponential Growth Drives The Valuation Cheaper
OptimizeRx Corporation is on a path of exponential topline growth. The company's valuation multiples are at the lowest levels in the company's history. The acquisition of Medicx is expected to boost OptimizeRx's revenue growth. OPRX provides a software suite that improves the reach of drug distributors to physicians and patients. The market has not reacted to their stellar guidance for 2024. The stock has a potential opportunity for a valuation re-rate in 2024.
Seeking Alpha · 6d ago
Weekly Report: what happened at OPRX last week (0311-0315)?
Weekly Report · 03/18 10:46
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)
TipRanks · 03/12 13:02
OptimizeRx provides update on the timing of earnings call
Seeking Alpha · 03/11 21:05
OptimizeRx Reaffirms Prior Revenue In The Range Of $68M-$70M Vs $69.85M Est. And Adjusted EBITDA Estimates For FY2023
OptimizeRx Corp. Reaffirms prior revenue and adjusted EBITDA estimates for FY2023. Company plans to hold a conference call on March 28, 2024 to discuss its financial results. The Company is working to complete its year end close and audit processes by the end of the year.
Benzinga · 03/11 20:35
*OptimizeRx Plans Conference Call March 28 To Discuss 4Q, FY23 Results>OPRX
Dow Jones · 03/11 20:33
*OptimizeRx: Based on Preliminary Review Of Results, FY23 Rev Expected To Exceed Range of $68-$70M>OPRX
Dow Jones · 03/11 20:33
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
OptimizeRx Corp. Provides an update on the anticipated timeline for its financial reporting. The company reaffirms prior revenue and adjusted EBITDA estimates for FY2023. OptimizeRx is the leading provider of healthcare technology solutions to life sciences companies and patients.
Barchart · 03/11 15:30
Weekly Report: what happened at OPRX last week (0304-0308)?
Weekly Report · 03/11 10:44
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
TipRanks · 03/05 14:00
Weekly Report: what happened at OPRX last week (0226-0301)?
Weekly Report · 03/04 10:46
Weekly Report: what happened at OPRX last week (0219-0223)?
Weekly Report · 02/26 10:56
OptimizeRx to Participate in Upcoming Investor Conferences
Barchart · 02/21 06:30
Weekly Report: what happened at OPRX last week (0212-0216)?
Weekly Report · 02/19 10:58
Bruker (BRKR) Q4 Earnings and Revenues Top Estimates
NASDAQ · 02/13 13:45
More
Webull provides a variety of real-time OPRX stock news. You can receive the latest news about Optimizerx Corp through multiple platforms. This information may help you make smarter investment decisions.
About OPRX
OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts.